Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

C-RAD AB: Företrädesemission tecknad till ca 165 procent

Detta pressmeddelande får inte offentliggöras, publiceras eller distribueras,vare sig direkt eller indirekt, i eller till, USA, Kanada, Japan, Australien,Nya Zeeland eller Sydafrika eller något annat land där distribution av dettapressmeddelande skulle strida mot tillämpliga lagar eller regler eller skullekräva att ytterligare handlingar upprättas eller registrering sker eller attnågon annan åtgärd företas utöver vad som krävs enligt svensk lag. Dettapressmeddelande är inte ett prospekt utan ett offentliggörande av ettemissionsresultat i enlighet med svenska lagar och regler.

REPURCHASE OF SHARES IN ASTRAZENECA PLC

Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 3 October 2011 to 16 December 2011, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 492,295 ordinary shares of AstraZeneca PLC at a price of 3027 pence per share on 24 October 2011. Upon the cancellation of these shares, the number of shares in issue will be 1,321,883,909. A C N Kemp Company Secretary 25 October 2011

Skanska sells office properties in Stockholm for a total of about SEK 1 billion

Skanska sells the office properties Gångaren 16 and Gångaren 20, at Lindhagensterrassen in Stockholm, to AFA Insurance. The selling price amounts to about SEK 550 M for Gångaren 16 and about SEK 460 M for Gångaren 20. The transaction will be recorded in the fourth quarter and the transfer is scheduled to take place on December 1, 2011.Both properties are located at Lindhagensterrassen on Kungsholmen. Gångaren 16 has a leasable property space of 12,000 square meters with an occupancy rate of 98 percent. The building is just completed and is built with high environmental performance and

Cision AB (publ) - Interim report January-September 2011, October 25, 2011

Cision returns to organic growthJuly–September · Operating revenue amounted to SEK 227 million (265). Organic growth was 2%, compared with –3% for the previous quarter and –4% for the same period last year. Exchange rate effects decreased revenue by SEK 22 million and the effect of divestments decreased revenue by SEK 19 million. · Operating profit amounted to SEK 29 million (36), including non-recurring items of SEK –2 million (–2), and the operating margin was 12.7% (13.5%). Exchange rate effects had a negative impact on operating profit of SEK 4 million. · Group organic growth

KARO BIO PREPARES SPIN-OFF OF PRECLINICAL DEVELOPMENT

STOCKHOLM, 25 October 2011 - Karo Bio AB (publ) is preparing a better allocation of resources and competences by spinning off the company’s preclinical activities. This part will therefore be transferred into a subsidiary that is intended to become autonomous in operations as well as by ownership. The subsidiary will be proposed to assume the name Karo Bio.Karo Bio is currently dominated by the eprotirome project which has very large potential. At the same time, it is among the world leaders in drug development of pharmaceuticals that act through nuclear receptors. This drug class

Skanska awarded green construction project in London worth GBP 50 M, about SEK 517 M

Skanska has been awarded a construction project in Bevis Marks, London. The contract amounts to GBP 50 M, about SEK 517 M, which will be included in order bookings for the fourth quarter. Customer is Bevis Marks Development.Work on the 16 storey commercial building, totaling 22,000 square meters, is due to start immediately with completion in autumn of 2013. The building has a target to achieve BREEAM Excellent. To deliver this, Skanska will incorporate elements such as combined heat and power generation, rainwater harvesting systems, energy saving lighting systems, condensing boilers,

INTERIM REPORT JANUARY–SEPTEMBER 2011

The January–September period and the third quarter 2011 in brief · Net sales amounted to MSEK 0.0 (0.0) · Net loss was MSEK 176.0 (113.4), whereof the third quarter MSEK 51.1 (34.4) · Loss per share was SEK 0.45 (0.48), whereof the third quarter SEK 0.13 (0.14) · Cash flow from operating activities was MSEK -160.4 (-114.6), whereof the third quarter MSEK -47.7 (-33.7).The difference from the previous period concerns costs related to the phase III program for eprotirome · Cash and cash equivalents and other short-term investments totalled MSEK 198.4 (116.2) at the end of the

Absilion to represent Sweden in Silicon Valley

Luleå, Sweden – Oct 25, 2011 – Absilion today announced that the company is selected as one of the Swedish representatives to participate during a weeklong program called “Innovative Sweden” taking place in Silicon Valley. The selected companies are all successful and expanding start-up companies who will meet experienced entrepreneurs, international industry representatives and venture capitalist firms. The event takes place on Nov 2 at Stanford University.Amazingly many great ideas come from Swedish inventors, such as the three point seat belt, the pacemaker and color graphics technology,

Strong Positioning for Precise Biometrics' Match-on-Card Technology - Interim Report Jan-Sept 2011

Precise Biometrics AB (publ), Corporate Identity No. 556545-6596 Interim Report for the period January – September 2011 · The group’s net sales for the interim period amounted to SEK 16.8 million (38.6) and for the third quarter SEK 7.4 million (12.2) · The group’s income for the interim period was SEK -24.0 million (-10.2) and for the third quarter SEK -5.4 million (-5.2). Compared to previous year the income for the interim period is lower primarily due to lower sales level impacted by the delayed US government budget process. · Earnings per share for the interim period was

Interim report January-September 2011: Continued Growth with High and Stable Profitability

Nine months · Order intake increased by 12% to 1,063.7 MSEK (945.6) · Net sales up by 20% to 1,072.4 MSEK (896.1) · Operating profit increased by 36% to 121.2 MSEK (89.3) · Profit after tax up by 33% to 84.0 MSEK (63.3) · Earnings per share increased by 33% to 4.28 SEK (3.22) · Share split creating 12.7 million new shares, to a total of 18.9 million shares Third quarter · Order intake up 16% to 332.3 MSEK (287.5) · Net sales increased by 14% to 342.5 MSEK (300.7) · Operating profit increased by 14% to 39.5 MSEK (34.7) · Profit after tax up by 13% to 26.5

Scania’s new global engine range ready for the future

Scania is taking the final steps towards a global engine platform based on the latest technology for all markets and for all emission standards. Strength, high performance and fuel efficiency are key characteristics. Easier servicing and parts supply contribute to improved uptime for operators.“After several years of development, we are taking the final steps towards a common global engine platform that is designed to meet all emission standards worldwide,” says Jonas Hofstedt, Head of Powertrain Development. Customer benefits include enhanced robustness, performance and fuel economy, as

Interim Report Q3 2011

1 JANUARY–30 SEPTEMBER 2011 (compared with same period a year ago)• Net sales decreased by 1% (increased by 6% excluding exchange rate effects and divestments) to SEK 79,001m (79,913) • Operating profit excluding restructuring costs decreased by 5% (decreased by 1% excluding exchange rate effects) to SEK 6,697m (7,041) • Restructuring costs totalled SEK 350m (931) • Earnings per share rose 2% (7% excluding exchange rate effects) to SEK 5.66 (5.53) • Cash flow from current operations was SEK 4,397m (5,010) • Operating profit for the third quarter, excluding restructuring

PONSSE'S INTERIM REPORT FOR 1 JANUARY - 30 SEPTEMBER 2011

PONSSE PLC, STOCK EXCHANGE RELEASE, 25 OCTOBER 2011, 9:00 a.m. PONSSE’S INTERIM REPORT FOR 1 JANUARY – 30 SEPTEMBER 2011 – Net sales amounted to EUR 225.5 (Q1–Q3/2010 171.8) million. - Q3 net sales were EUR 72.3 (Q2/2008 54.7) million. – Operating result totalled EUR 18.6 (Q1-Q3/2008 15.3) million, equalling 8.2 (8.9) per cent of net sales. The result includes a write-down of EUR 2.6 million on external trade receivables in South America. – Q3 operating result was EUR 8.2 (Q2/2010 5.4) million, equalling 11.4 (10.0) per cent of net sales. – Profit before taxes was EUR 14.1

Lindab supplies ventilation system worth around SEK 12 million for Audi's production facility in Hungary

Lindab has received an order worth approximately SEK 12 m to deliver the ventilation system for the extension of Audi's car production plant in Györ in north-west Hungary. The order includes Lindab's circular ducts and fittings and will be delivered to a tight time schedule between now and March 2012.  Lindab's President and CEO, David Brodetsky, commented:"The Hungarian economy has suffered greatly since the downturn. The fact that Audi is making a EUR 900 million investment and will create 1,800 new jobs sends a positive signal." David Brodetsky continues:"We are very pleased to

BioGaia AB : Interim report 1 January - 30 September 2011

BioGaia AB Interim report 1 January - 30 September 2011(Figures in brackets refer to the same period of last year)Interim period, 1 January - 30 September 2011-    Net sales reached SEK 232.6 million (173.3), an increase of SEK 59.3 million (34%). Excluding foreign exchange effects, the increase in net sales was 43%1).-    Operating profit was SEK 79.4 million (40.1)2), an improvement of SEK 39.3 million (98%). Excluding foreign exchange effects, operating profit rose by 121%1).-    Profit before tax was SEK 79.2 million (51.1) 2), an increase of SEK 28.1 million (55%). Net

Precise Biometrics Appoints GD Burti as Exclusive Distributor of Their Fingerprint & Smartcard Readers in Brazil

Precise Biometrics has chosen GD Burti, Giesecke & Devrient’s Brazilian subsidiary, to be the exclusive distributor of its fingerprint/smartcard readers in Brazil. G&D is expecting a large demand for biometric card readers in Brazil following the rollout of the Brazilian National ID and is well-positioned to play an important role in the project.The Brazilian national ID card will provide all Brazilian citizens with a unique credential. The chip will contain the person’s fingerprints, enabling them to be securely identified, so their information cannot be stolen or used by other individuals.

Lindab's report for the Third Quarter 2011

Third Quarter 2011 · Sales revenue increased by 1 percent to SEK 1,891 m (1,881), an increase of 4 percent when adjusted for currency and structure · Operating profit (EBIT) amounted to SEK 172 m (212), excluding one-off items of SEK 0 m (-7). · The operating margin (EBIT), excluding one-off items, amounted to 9.1 percent (11.3). · The after-tax result amounted to SEK 88 m (114). · Earnings per share amounted to SEK 1.17 (1.51). · Cash flow from operating activities amounted to SEK 115 m (172). January - September 2011 · Sales revenue increased by 4 percent to

Volvo Group – report on the third quarter 2011

During the third quarter of 2011, demand remained favorable in most of the Volvo Group’s markets. Sales rose to SEK 73.3 billion. Operating income improved to SEK 5.8 billion, compared with SEK 4.9 billion in the year-earlier period, corresponding to an operating margin of 7.9% (7.7). Operating cash flow in the industrial operations amounted to SEK 2.2 billion. ·In the third quarter, net sales increased by 15% to SEK 73.3 billion (64.0). Adjusted for currency movements and acquired and divested units, sales increased by 22%.  ·The third quarter operating income amounted to SEK

Interim Report January- September

Third quarter 2011Compared with the second quarter 2011 - The result for the quarter amounted to SEK 3 475m (3 452)- Earnings per share before dilution amounted to SEK 3.12* (3.02) and earnings per share after dilution amounted to SEK 3.11* (3.01)- The return on equity was 14.4 per cent (14.4)- The cost/income ratio was 0.53 (0.52)- Net interest income was SEK 4 857m (4 740)- Profit before impairments decreased by 4 per cent to SEK 3 859m (4 010)- Swedbank reported net recoveries of SEK 441m (324)- The core Tier 1 capital ratio was 15.1 per cent according to Basel 2 (13.9

Norse Energy Announces EGM Request

October 24, 2011Norse Energy Corp. ASA (“NEC” ticker Oslo Stock Exchange, Norway; “NSEEY” ticker U.S. OTC) announces that it has received a request for an Extraordinary General Meeting (EGM) from a shareholder’s group indicating that it represents more than five percent of outstanding Norse shares. The stated purpose of those requesting the meeting is to address replacing board members Dag Erik Rasmussen and Katherine Stovring with Cecilie Amdahl and former Norse CEO Oivind Risberg, respectively. Norse anticipates sending out shortly formal notice of an EGM, with the meeting expected to

Regent Surgical Health to Speak at 2011 Becker’s ASC Annual Conference

Speakers to Cover Topics Ranging from ASC Demand to Partnership ModelsWestchester, IL (Oct 24, 2011)--Regent Surgical Health, a leading manager and developer of ambulatory surgery centers, is pleased to announce that seven of its executives will be speaking at the 18thAnnual Ambulatory Surgical Center Conference, hosted by Becker’s ASC Review. This year’s conference, “Improving Profitability & Business and Legal Issues” will be held from Oct. 27 - Oct. 29 at the Westin Michigan Avenue in Chicago. The schedule for Regent speakers is as follows: Thursday, Oct. 27: 3:10        Vivek

Eriez® Xtreme® Rare Earth Rota-Grates®

Eriez® Xtreme® Rare Earth Rota-Grates® Provide Speedy and Automatic Removal of Clogging Contaminants from Processing LinesErie, Pa. — Eriez® Xtreme® Rare Earth Rota-Grates® feature a unique rotating design to remove both large and small ferrous contaminants that tend to stick, clog and bridge when passed through traditional grate magnets. Eriez’ Rota-Grate reel incorporates Xtreme Rare Earth tube circuits, which are at least 12 percent stronger than ALL other existing magnets! Eriez Xtreme Rare Earth Rota-Grates provide unmatched efficiency on many finely ground cohesive materials such

LifeGas to highlight flexible home oxygen solutions at Medtrade Exposition

ATLANTA, October 24, 2011 – Businesses operating in the homecare industry are faced with ever-changing economic environments that demand perseverance and flexibility in order to stay successful. At the 2011 Medtrade Exposition  in Atlanta, Georgia, from October 25-27, 2011, LifeGas  experts will be available to discuss ways for homecare companies to overcome these challenges.   LifeGas is the U.S. medical gas business of Linde North America, a member of The Linde Group, a world-leading gases and engineering company. LifeGas was

Oasmia announces launch of private placement of new shares

Oasmia Pharmaceutical AB (publ) (“Oasmia” or the “Company”) announces the launch of a private placement of new shares through a directed new share issue. Oasmia has retained Carnegie Investment Bank as placing agent in a private placement of new shares (the “New Shares”) directed towards qualified investors in Sweden (the "Private Placement"). The Private Placement will be carried out with deviation from the shareholders’ preferential rights and in accordance with the AGM’s resolution, on September 30, 2011, to authorize the Board of Directors in Oasmia to, at one or several occasions

There are no items matching the current filter
There are no more items matching the current filter
Back to top